Solitary pulmonary nodules: potential role of dynamic MR imaging in management initial experience.

PURPOSE To evaluate the utility of dynamic magnetic resonance (MR) imaging in the management of solitary pulmonary nodules (SPNs). MATERIALS AND METHODS Fifty-eight patients with 58 pathologic analysis-proved SPNs (diameter < 30 mm) underwent dynamic 1.5-T MR imaging. The 58 SPNs were classified into three groups at pathologic analysis: malignant SPNs (n = 38), active infections (n = 10), or benign SPNs (n = 10). From signal intensity-time curves generated after the bolus injection of contrast material, the maximum relative enhancement ratio and slope of enhancement were calculated and statistically compared among the three groups. Threshold values of these two dynamic MR indexes were determined on the basis of positive differentiations. RESULTS The mean relative enhancement ratio and mean slope of enhancement for the malignant SPN group were significantly higher than those for the benign SPN group and significantly lower than those for the active infection group (P <.05). With 0.15 as the threshold maximum relative enhancement ratio for distinguishing the malignant SPN and active infection groups from the benign SPN group, the sensitivity, specificity, and accuracy were 100%, 70%, and 95%, respectively. With 0.025/sec as the threshold slope of enhancement, all SPNs with malignancy and active infection were clearly distinguished from benign SPNs. CONCLUSION Dynamic MR indexes were useful in the differentiation between SPNs that necessitated further evaluation or treatment (malignancy and active infection) and SPNs that did not necessitate further evaluation or treatment (benign nodules).

[1]  H. Lodish,et al.  Elevated levels of glucose transport and transporter messenger RNA are induced by ras or src oncogenes. , 1987, Science.

[2]  A. Wolf,et al.  Metabolic trapping as a principle of oradiopharmaceutical design: some factors resposible for the biodistribution of [18F] 2-deoxy-2-fluoro-D-glucose. , 1978, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[3]  H. Hatabu,et al.  Fast magnetic resonance imaging of the lung. , 1999, European journal of radiology.

[4]  G. V. von Schulthess,et al.  Infection imaging using whole-body FDG-PET , 2000, European Journal of Nuclear Medicine.

[5]  M. Kusumoto,et al.  Gadopentetate-dimeglumine-enhanced magnetic resonance imaging for lung nodules. Differentiation of lung cancer and tuberculoma. , 1994, Investigative radiology.

[6]  M. Kusumoto,et al.  Clinical utility of Gd‐DTPA-enhanced magnetic resonance imaging in lung cancer , 1993, Journal of thoracic imaging.

[7]  R. Coleman,et al.  Focal pulmonary abnormalities: evaluation with F-18 fluorodeoxyglucose PET scanning. , 1993, Radiology.

[8]  L. Kostakoglu,et al.  Role of nuclear medicine in the evaluation of the solitary pulmonary nodule. , 2000, Seminars in ultrasound, CT, and MR.

[9]  R R Edelman,et al.  Pulmonary perfusion: Qualitative assessment with dynamic contrast‐enhanced MRI using ultra‐short TE and inversion recovery turbo FLASH , 1996, Magnetic resonance in medicine.

[10]  P. Ercolani,et al.  Dynamic MRI of the breast. , 1998, European journal of radiology.

[11]  M. Gaeta,et al.  Carcinomatous solitary pulmonary nodules: evaluation of the tumor-bronchi relationship with thin-section CT. , 1993, Radiology.

[12]  T. Ichikawa,et al.  Fast magnetic resonance imaging of liver. , 1999, European journal of radiology.

[13]  E. Milne.  Circulation of primary and metastatic pulmonary neoplasms. A postmortem microarteriographic study. , 1967, The American journal of roentgenology, radium therapy, and nuclear medicine.

[14]  A. Celler,et al.  Pulmonary nodules: differential diagnosis using 18F-fluorodeoxyglucose single-photon emission computed tomography. , 1997, AJR. American journal of roentgenology.

[15]  David A. Cheresh,et al.  Detection of tumor angiogenesis in vivo by αvβ3-targeted magnetic resonance imaging , 1998, Nature Medicine.

[16]  R. Dhand,et al.  The role of bronchial circulation in lung abscess. , 2015, The American review of respiratory disease.

[17]  S J Swensen,et al.  Lung nodule enhancement at CT: prospective findings. , 1996, Radiology.

[18]  R. Paola,et al.  Correlation Between Contrast Enhancement in Dynamic Magnetic Resonance Imaging of the Breast and Tumor Angiogenesis , 1994, Investigative radiology.

[19]  E A Zerhouni,et al.  Blood supply of pulmonary metastases , 1987, Journal of thoracic imaging.

[20]  L. Cudkowicz.  Some observations of the bronchial arteries in lobar pneumonia and pulmonary infarction. , 1952, The British journal of tuberculosis and diseases of the chest.

[21]  W. Steinbrich,et al.  Solitary pulmonary nodules: MR evaluation of enhancement patterns with contrast-enhanced dynamic snapshot gradient-echo imaging. , 1996, Radiology.

[22]  J. T. Littleton,et al.  Pulmonary masses: contrast enhancement. , 1990, Radiology.

[23]  G Brix,et al.  Pathophysiologic basis of contrast enhancement in breast tumors , 1999, Journal of magnetic resonance imaging : JMRI.

[24]  J Konishi,et al.  Solitary pulmonary nodule: preliminary study of evaluation with incremental dynamic CT. , 1995, Radiology.

[25]  J Listerud,et al.  T2* and proton density measurement of normal human lung parenchyma using submillisecond echo time gradient echo magnetic resonance imaging. , 1999, European journal of radiology.

[26]  Dynamic magnetic resonance imaging of head and neck lesions. , 1999, Topics in magnetic resonance imaging : TMRI.

[27]  W. Webb.  Radiologic evaluation of the solitary pulmonary nodule. , 1990, AJR. American journal of roentgenology.

[28]  S J Swensen,et al.  Solitary pulmonary nodule: CT evaluation of enhancement with iodinated contrast material--a preliminary report. , 1992, Radiology.

[29]  P. Dean,et al.  Comparative pharmacokinetics of gadolinium DTPA and gadolinium chloride. , 1988 .

[30]  M P Frick,et al.  Diagnostic efficacy of PET-FDG imaging in solitary pulmonary nodules. Potential role in evaluation and management. , 1993, Chest.

[31]  R. D. Wright.  The blood supply of abnormal tissues in the lungs , 1938 .

[32]  R. Edelman,et al.  Pulmonary perfusion and angiography: evaluation with breath-hold enhanced three-dimensional fast imaging steady-state precession MR imaging with short TR and TE. , 1996, AJR. American journal of roentgenology.

[33]  M Kono,et al.  Solitary pulmonary nodules: evaluation of blood flow patterns with dynamic CT. , 1997, Radiology.

[34]  J. Goo,et al.  Pulmonary tuberculoma evaluated by means of FDG PET: findings in 10 cases. , 2000, Radiology.

[35]  E. Gunel,et al.  Probability of malignancy in solitary pulmonary nodules using fluorine-18-FDG and PET. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[36]  N. Müller,et al.  Lung nodule enhancement at CT: multicenter study. , 2000, Radiology.

[37]  M. Schwaiger,et al.  Controlled prospective study of positron emission tomography using the glucose analogue [18F]fluorodeoxyglucose in the evaluation of pulmonary nodules , 1998, The British journal of surgery.

[38]  R R Edelman,et al.  Quantitative assessment of pulmonary perfusion with dynamic contrast‐enhanced MRI , 1999, Magnetic resonance in medicine.

[39]  D. Saloner,et al.  Evaluation of myocardial perfusion abnormalities with gadolinium-enhanced snapshot MR imaging in humans. Work in progress. , 1992, Radiology.